血友病
预期寿命
医学
血友病B
凝血因子
血友病A
疾病
因子IX
凝结
血管性血友病因子
重症监护医学
儿科
免疫学
精神科
内科学
人口
血小板
环境卫生
作者
Paula Bolton‐Maggs,John Pasi
出处
期刊:The Lancet
[Elsevier]
日期:2003-05-01
卷期号:361 (9371): 1801-1809
被引量:695
标识
DOI:10.1016/s0140-6736(03)13405-8
摘要
The haemophilias are inherited disorders in which one of the coagulation factors is deficient. Although deficiencies of factor VIII (haemophilia A) and factor IX (haemophilia B) are well recognised, von Willebrand's disease is much more common. Rare defects can occur in any of the coagulation factors. In the past, men with haemophilia were likely to die in their youth. With advances in diagnosis, and especially with development of safe and effective treatment, affected individuals can now look forward to a normal life expectancy. Complications of the disorder, particularly the development of antibodies that make treatment ineffective, and of treatment, such as transfusion-transmitted infections, have taken a severe toll on these patients. The future holds the realistic possibility of gene therapy. However, we must not forget that haemophilia is a worldwide disorder that requires significant economic resources not available for the majority.
科研通智能强力驱动
Strongly Powered by AbleSci AI